皮肤癌切除后重建的循证临床实践指南
多学科工作组针对皮肤癌切除后重建管理制定循证指南,采用系统文献综述与GRADE方法评价证据质量。最终推荐涉及重建时机、抗凝管理、抗生素使用、疼痛控制和随访评估,部分领域证据不足。文献分析强调需更多方法学严谨的研究指导临床实践。
要点
- 指南推荐覆盖重建时机、抗凝、抗生素、疼痛控制与随访评估。
- 部分临床问题因证据不足无法给出高级别推荐。
- 需更多方法学严谨的研究以指导皮肤癌切除后重建实践。
核心结论
- 指南针对皮肤癌切除后重建的常见环节给出循证推荐,并指出部分领域证据不足。
研究设计与样本
- 多学科工作组开展系统文献综述,采用GRADE方法评价证据质量并形成推荐。
主要发现
- 最终推荐涉及重建时机、抗凝管理、抗生素使用、疼痛控制和随访评估。
- 部分临床问题因证据不足未能形成高级别推荐。
关键数值与推荐
- 推荐条款涵盖重建时机、抗凝管理、抗生素使用、疼痛控制及随访评估。
临床怎么用
- 临床可参照指南推荐优化皮肤癌切除后重建的时机、抗凝、抗生素、镇痛与随访管理。
局限性
- 部分领域证据不足,无法给出高级别推荐。
- 文献分析提示该领域需更多方法学严谨的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A multi-disciplinary work group involving stakeholders from various backgrounds and societies was convened to develop guidelines for the management of reconstruction after skin cancer resection. The goal was to identify areas of common ground and provide evidence-based recommendations to improve patient care. Given the heterogeneity of reconstructive techniques and clinical scenarios, investigation centered around common elements in the process. In some cases, a distinction was made between treatment options in the office-based setting as opposed to those in the facility setting. A systematic literature review was performed, and an established appraisal process was used to rate the quality of relevant scientific research (Grading of Recommendations Assessment, Development, and Evaluation methodology). Final recommendations are related to concepts concerning the timing of reconstruction, management of anticoagulation, use of antibiotics, methods of pain control, and follow-up assessment. At times, there was insufficient evidence to make high-level recommendations. The literature analysis highlights the need for additional methodologically robust studies in this area, to help guide clinical practice.
引用
- Chen A, Albertini JG, Bordeaux JS, et al. Evidence-based clinical practice guideline: Reconstruction after skin cancer resection. J Am Acad Dermatol. 2021. PMID: 33931288. doi:10.1016/j.jaad.2021.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。